|Day Low/High||6.01 / 6.41|
|52 Wk Low/High||3.71 / 18.98|
The price of ACB is moving up today and a fresh look at the charts and indicators seems like a good idea.
Aurora's addition of a big name activist is accelerating share growth.
In its first report on cannabis companies, Melius says prices are high.
I tend to focus more on individual stocks I'm holding rather than try to predict what the indices will do next.
The best move here is to stay focused on stock picking but manage positions tightly.
Right now they are speculative growth stocks through and through.
The company's first move into the cannabis space is in a joint venture with medical marijuana research company Emerald Farms.
I see two factors coming into play as the company reports earnings.
Without Apple doing so well Monday the indices would look much different.
Let's check out the charts of four big names in the space.
CBD could make coffee an around the clock craze.
Establishing who the stragglers are and what impact they might have in the future is the key at this point.
Shares of Tilray, Canopy Growth and Aurora Cannabis are down sharply on Wednesday.
Perhaps the highest profile impact on Tilray equity performance has been the interest of Andrew Left of Citron Research.
Companies are adjusting their supply lines, but both the U.S. and Chinese administrations are feeling the heat.
Consumer Discretionary stocks were the hottest on Wednesday, though all eleven sectors easily finished in the green.
An early look at the market shows supply is finding it tough to keep up with demand.
These are where my focus is until we see correlation wane.